<DOC>
	<DOCNO>NCT00641979</DOCNO>
	<brief_summary>The purpose study compare efficacy daily dose Rhinocort Aqua ( new formulation ) Rhinocort Aqua ( current formulation ) placebo relive symptom seasonal allergic rhinitis ( SAR ) .</brief_summary>
	<brief_title>New Nasal Applicator / New Formulation - User Study</brief_title>
	<detailed_description />
	<mesh_term>Rhinitis , Allergic</mesh_term>
	<mesh_term>Rhinitis</mesh_term>
	<mesh_term>Rhinitis , Allergic , Seasonal</mesh_term>
	<mesh_term>Budesonide</mesh_term>
	<criteria>In opinion investigator , candidate treatment nasal steroid base history either ) inadequate control symptoms antihistamine , decongestant and/or immunotherapy , b ) prior successful treatment nasal steroid . A documented history least one year seasonal allergic rhinitis . A positive response skin prick test grass allergens must present subject 's environment throughout study . Primary secondary adrenal insufficiency Nasal candidiasis , rhinitis medicamentosa , acute chronic sinusitis , influenza , upper respiratory tract infection structural abnormality nose ( e.g. , septal deviation , nasal polyp ) symptomatic enough cause significant nasal obstruction judge investigator . A diagnosis asthma require treatment specify protocol .</criteria>
	<gender>All</gender>
	<minimum_age>6 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>January 2011</verification_date>
	<keyword>Allergic rhinitis</keyword>
	<keyword>Nasal symptom</keyword>
	<keyword>Congestion</keyword>
	<keyword>Rhinorrhea</keyword>
	<keyword>Sneeze</keyword>
	<keyword>budesonide</keyword>
	<keyword>Rhinocort AQUA</keyword>
</DOC>